CHF360.30
0.85%
SIX Swiss Exchange, Sep 25, 05:31 pm CEST. Closed.
ISIN
CH1499059983
Symbol
ROP
Index

Roche Target price 2026 - Analyst rating & recommendation

Roche Classifications & Recommendation

Buy
46%
Hold
39%
Sell
14%

Roche Price Target

Target Price CHF387.60
Price CHF360.30
Potential 7.58%
Number of Estimates 23
23 Analysts have issued a price target Roche 2027 . The average Roche target price is CHF387.60. This is 7.58% higher than the current stock price. The highest price target is CHF456.23 26.62% , the lowest is CHF303.00 15.90% .
A rating was issued by 28 analysts: 13 Analysts recommend Roche to buy, 11 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Roche stock has an average upside potential 2027 of 7.58% . Most analysts recommend the Roche stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CHF 61.52 63.98
1.69% 4.01%
EBITDA Margin 35.48% 40.15%
5.02% 13.16%
Net Margin 20.94% 3.30%
53.03% 84.24%

25 Analysts have issued a sales forecast Roche 2026 . The average Roche sales estimate is

CHF64.0b
unlock
. This is
688.43% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF70.0b 762.58%
unlock
, the lowest is
CHF60.0b 638.82%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF61.5b 1.69%
2026
CHF64.0b 4.01%
unlock
2027
CHF66.7b 4.26%
unlock
2028
CHF70.1b 5.15%
unlock
2029
CHF71.2b 1.45%
unlock
2030
CHF73.4b 3.14%
unlock
2031
CHF74.9b 1.99%
unlock
2032
CHF76.9b 2.73%
unlock
2033
CHF17.9b 76.77%
unlock

23 Analysts have issued an Roche EBITDA forecast 2026. The average Roche EBITDA estimate is

CHF25.7b
unlock
. This is
704.05% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF29.3b 816.33%
unlock
, the lowest is
CHF22.7b 609.96%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 CHF21.8b 6.79%
2026
CHF25.7b 17.69%
unlock
2027
CHF27.5b 6.99%
unlock
2028
CHF29.2b 6.18%
unlock
2029
CHF31.3b 7.39%
unlock
2030
CHF33.0b 5.41%
unlock
2031
CHF35.7b 8.15%
unlock
2032
CHF37.1b 3.83%
unlock
2033
CHF35.3b 4.73%
unlock

EBITDA Margin

2025 35.48% 5.02%
2026
40.15% 13.16%
unlock
2027
41.20% 2.62%
unlock
2028
41.60% 0.97%
unlock
2029
44.04% 5.87%
unlock
2030
45.01% 2.20%
unlock
2031
47.73% 6.04%
unlock
2032
48.24% 1.07%
unlock

25 Roche Analysts have issued a net profit forecast 2026. The average Roche net profit estimate is

CHF2.1b
unlock
. This is
23.29% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF2.4b 39.50%
unlock
, the lowest is
CHF2.0b 15.10%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF12.9b 55.61%
2026
CHF2.1b 83.59%
unlock
2027
CHF2.3b 7.56%
unlock
2028
CHF2.4b 7.71%
unlock
2029
CHF2.8b 14.25%
unlock
2030
CHF2.9b 4.88%
unlock
2031
CHF3.1b 4.65%
unlock
2032
CHF3.2b 4.62%
unlock

Net Margin

2025 20.94% 53.03%
2026
3.30% 84.24%
unlock
2027
3.41% 3.33%
unlock
2028
3.49% 2.35%
unlock
2029
3.93% 12.61%
unlock
2030
4.00% 1.78%
unlock
2031
4.10% 2.50%
unlock
2032
4.18% 1.95%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CHF 16.04 20.64
55.43% 28.68%
P/E 17.46
EV/Sales 4.70

25 Analysts have issued a Roche forecast for earnings per share. The average Roche EPS is

CHF20.64
unlock
. This is
26.01% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CHF23.35 42.55%
unlock
, the lowest is
CHF19.27 17.64%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF16.04 55.43%
2026
CHF20.64 28.68%
unlock
2027
CHF22.20 7.56%
unlock
2028
CHF23.91 7.70%
unlock
2029
CHF27.32 14.26%
unlock
2030
CHF28.65 4.87%
unlock
2031
CHF29.98 4.64%
unlock
2032
CHF31.37 4.64%
unlock
2033
CHF32.70 4.24%
unlock

P/E ratio

Current 22.00 14.37%
2026
17.46 20.62%
unlock
2027
16.23 7.04%
unlock
2028
15.07 7.15%
unlock
2029
13.19 12.48%
unlock
2030
12.58 4.62%
unlock
2031
12.02 4.45%
unlock
2032
11.49 4.41%
unlock

Based on analysts' sales estimates for 2026, the Roche stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 37.04 887.73%
2026
4.70 87.32%
unlock
2027
4.51 4.08%
unlock
2028
4.29 4.90%
unlock
2029
4.22 1.43%
unlock
2030
4.10 3.04%
unlock
2031
4.02 1.95%
unlock
2032
3.91 2.66%
unlock

P/S ratio

Current 35.80 933.51%
2026
4.54 87.32%
unlock
2027
4.36 4.08%
unlock
2028
4.14 4.90%
unlock
2029
4.08 1.43%
unlock
2030
3.96 3.04%
unlock
2031
3.88 1.95%
unlock
2032
3.78 2.66%
unlock

Current Roche Upgrades & Downgrades

Analyst Rating Action Date
BERENBERG
Hold
➜
Hold
Unchanged Sep 23 2026
JEFFERIES
Underperform
➜
Underperform
Unchanged Sep 03 2026
HSBC GLOBAL INVESTMENT RESEARCH
Buy
➜
Hold
Downgrade Aug 24 2026
TD COWEN
Hold
➜
Hold
Unchanged Aug 10 2026
ROTHSCHILD & CO REDBURN
Buy
➜
Buy
Unchanged Jul 27 2026
TD COWEN
Hold
➜
Hold
Unchanged Jul 15 2026
ROTHSCHILD & CO REDBURN
Buy
➜
Buy
Unchanged Jul 14 2026
Analyst Rating Date
Unchanged
BERENBERG:
Hold
➜
Hold
Sep 23 2026
Unchanged
JEFFERIES:
Underperform
➜
Underperform
Sep 03 2026
Downgrade
HSBC GLOBAL INVESTMENT RESEARCH:
Buy
➜
Hold
Aug 24 2026
Unchanged
TD COWEN:
Hold
➜
Hold
Aug 10 2026
Unchanged
ROTHSCHILD & CO REDBURN:
Buy
➜
Buy
Jul 27 2026
Unchanged
TD COWEN:
Hold
➜
Hold
Jul 15 2026
Unchanged
ROTHSCHILD & CO REDBURN:
Buy
➜
Buy
Jul 14 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today